These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9085557)

  • 21. Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-beta-cyclodextrin.
    Matsubara K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):378-83. PubMed ID: 9118452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: cavity size dependency.
    Ikeda Y; Hirayama F; Arima H; Uekama K; Yoshitake Y; Harano K
    J Pharm Sci; 2004 Jul; 93(7):1659-71. PubMed ID: 15176056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.
    Shiotani K; Uehata K; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2332-7. PubMed ID: 7859332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
    Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate.
    Celia C; Scala A; Stancanelli R; Surdo E; Paolino D; Grattoni A; Micale N; Crupi V; Majolino D; Fresta M; Tommasini S; Venuti V; Ventura CA
    Int J Pharm; 2017 Dec; 534(1-2):316-324. PubMed ID: 29042336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.
    Hirayama F; Kurihara M; Horiuchi Y; Utsuki T; Uekama K; Yamasaki M
    Pharm Res; 1993 Feb; 10(2):208-13. PubMed ID: 8384365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR spectroscopic investigation of inclusion complexes between cyclodextrins and the neurotoxin tetramethylenedisulfotetramine.
    Mayer BP; Albo RL; Hok S; Valdez CA
    Magn Reson Chem; 2012 Mar; 50(3):229-35. PubMed ID: 22383439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].
    Hirayama F
    Yakugaku Zasshi; 1993 Jun; 113(6):425-37. PubMed ID: 8355145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
    Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
    Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
    Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
    J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prominent inclusion effect of dimethyl-beta-cyclodextrin on photoisomerization of the thromboxane synthetase inhibitor (E)-4-(1-imidazoylmethyl)cinnamic acid.
    Hirayama F; Utsuki T; Uekama K; Yamasaki M; Harata K
    J Pharm Sci; 1992 Aug; 81(8):817-22. PubMed ID: 1403730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
    Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-O-alpha-(4-O-alpha-D-glucuronyl)-D-glucosyl-beta-cyclodextrin: solubilizing ability and some cellular effects.
    Tavornvipas S; Hirayama F; Arima H; Uekama K; Ishiguro T; Oka M; Hamayasu K; Hashimoto H
    Int J Pharm; 2002 Dec; 249(1-2):199-209. PubMed ID: 12433448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of dissolution properties of a new Helicobacter pylori eradicating agent (TG44) by inclusion complexation with beta-cyclodextrin.
    Anzai K; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1466-70. PubMed ID: 17917290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
    Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
    J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.